The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Contreras Jaime since 2013.
The trader's CIK number is 1587070.
At the time of the last reporting, Contreras Jaime was the Senior Vice President of Abbott Laboratories. (stock ticker symbol ABT).
Also see all insider trading activities at Abbott Laboratories.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | ABT | 0 | $0 | 2,001 | $155,857 | 108,412 | $6,513,392 |
| 2019 | ABT | 0 | $0 | 273,668 | $19,264,594 | 517,879 | $22,670,622 |
| 2018 | ABT | 0 | $0 | 167,194 | $11,108,763 | 172,468 | $6,386,490 |
| 2017 | ABT | 0 | $0 | 66,622 | $3,366,837 | 52,700 | $1,328,250 |
| 2016 | ABT | 0 | $0 | 11,079 | $432,729 | 0 | $0 |
| 2015 | ABT | 0 | $0 | 9,860 | $466,107 | 0 | $0 |
| 2014 | ABT | 0 | $0 | 66,602 | $2,891,807 | 57,900 | $1,525,192 |
| 2013 | ABT | 0 | $0 | 25,368 | $936,561 | 25,368 | $875,449 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-04-21 | ABT | Option Ex | 108,412 | 60.08 | 6,513,392 |
| 2020-03-02 | ABT | Sale | 2,001 | 77.89 | 155,857 |
| 2019-04-25 | ABT | Option Ex | 82,732 | 52.17 | 4,316,128 |
| 2019-04-26 | ABT | Option Ex | 80,860 | 38.40 | 3,105,024 |
| 2019-04-25 | ABT | Sale | 82,732 | 70.01 | 5,792,067 |
| 2019-04-22 | ABT | Sale | 918 | 73.12 | 67,124 |
| 2019-03-01 | ABT | Sale | 12,561 | 78.29 | 983,413 |
| 2019-01-30 | ABT | Sale | 177,457 | 70.00 | 12,421,990 |
| 2019-01-31 | ABT | Option Ex | 140,150 | 42.70 | 5,984,405 |
| 2019-01-30 | ABT | Option Ex | 214,137 | 43.27 | 9,265,065 |
| 2018-08-29 | ABT | Sale | 95,793 | 66.71 | 6,390,255 |
| 2018-08-29 | ABT | Option Ex | 172,468 | 37.03 | 6,386,490 |
| 2018-08-29 | ABT | Sale | 64,268 | 66.83 | 4,294,837 |
| 2018-04-23 | ABT | Sale | 849 | 59.36 | 50,396 |
| 2018-03-01 | ABT | Sale | 6,284 | 59.40 | 373,275 |
| 2017-09-22 | ABT | Sale | 52,700 | 52.00 | 2,740,452 |
| 2017-09-22 | ABT | Option Ex | 52,700 | 25.20 | 1,328,250 |
| 2017-03-31 | ABT | Sale | 767 | 44.64 | 34,239 |
| 2017-02-28 | ABT | Sale | 13,155 | 45.01 | 592,146 |
| 2016-03-31 | ABT | Sale | 462 | 41.78 | 19,304 |
| 2016-02-29 | ABT | Sale | 10,617 | 38.94 | 413,425 |
| 2015-03-31 | ABT | Sale | 228 | 46.43 | 10,586 |
| 2015-03-02 | ABT | Sale | 9,209 | 47.34 | 435,954 |
| 2015-02-18 | ABT | Sale | 423 | 46.26 | 19,567 |
| 2014-11-25 | ABT | Sale | 51,600 | 44.07 | 2,274,218 |
| 2014-11-25 | ABT | Option Ex | 51,600 | 26.36 | 1,359,969 |
| 2014-11-10 | ABT | Sale | 6,300 | 43.68 | 275,209 |
| 2014-11-10 | ABT | Option Ex | 6,300 | 26.23 | 165,223 |
| 2014-03-03 | ABT | Sale | 8,081 | 39.38 | 318,189 |
| 2014-02-18 | ABT | Sale | 621 | 38.95 | 24,191 |
| 2013-10-30 | ABT | Option Ex | 25,368 | 34.51 | 875,449 |
| 2013-10-30 | ABT | Sale | 25,368 | 36.92 | 936,561 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Contreras Jaime (Senior Vice President of Abbott Laboratories at the time of this reporting) see the Securities and Exchange Commission (SEC) website.